Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion type Assertion NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_head.
- NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_provenance.
- NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion evidence source_evidence_literature NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_provenance.
- NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion SIO_000772 23197570 NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_provenance.
- NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion wasDerivedFrom befree-20140225 NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_provenance.
- NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion wasGeneratedBy ECO_0000203 NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_provenance.